2160
A. K. Prasad et al. / Bioorg. Med. Chem. Lett. 18 (2008) 2156–2161
S.; Prasad, A. K.; Sharma, G. L. Bioorg. Med. Chem.
2006, 14, 973.
pathogenic fungal and bacterial strains were found to be
almost non-toxic up to concentrations of 250 lg/ml
(Fig. 1). The most interesting observation was that 2c
having strong activity against Aspergillus species did
not show any toxicity up to a concentration of
4000 lg/ml. The well-known drugs amphotericin B, tet-
racycline, and gentamycin lysed 100%, 11.68%, and
5.22% erythrocytes, respectively, at a concentration of
62.5 lg/ml. At a very low concentration (3.91 lg/ml),
the well-known drug gentamycin did not show any tox-
icity while amphotericin B and tetracycline lysed 5.52%
and 4.26% erythrocytes. Our results are in accordance
with the results of Cybulska et al.,32 who have reported
that 1.70 lg/ml of amphotericin B caused 50% haemo-
globin loss from erythrocytes.
6. Rogers, G. A.; Parsons, S. M.; Anderson, D. C.; Nilsson,
L. M.; Bahr, B. A.; Kornreich, W. D.; Kaufman, R.;
Jacobs, R. S.; Kirtman, B. J. Med. Chem. 1989, 32, 1217.
7. Johannes, C. W.; Visser, M. S.; Weatherhead, G. S.;
Hoveyda, A. H. J. Am. Chem. Soc. 1998, 120, 8340.
8. Li, G.; Chang, H. T.; Sharpless, K. B. Angew. Chem. Int.
Ed. 1996, 35, 451.
9. Ager, D. J.; Prakash, I.; Schaad, D. R. Chem. Rev. 1996,
96, 835.
10. Kimura, M.; Masuda, T.; Yamada, K.; Kawakatsu, N.;
Kubota, N.; Mitani, M.; Kishii, K.; Inazu, M.; Kiuchi, Y.;
Oguchi, K.; Namiki, T. Bioorg. Med. Chem. Lett. 2004, 14,
4287.
11. Carter, H. E.; Glick, F. J.; Norris, W. P.; Phillips, G. E. J.
Biol. Chem. 1947, 170, 285.
12. Jnaneshwara, G. K.; Deshpande, V. H.; Lalithambika,
M.; Ravindranathan, T.; Bedekar, A. V. Tetrahedron Lett.
1998, 39, 459.
13. Auvin-Guette, C.; Rebuffat, S.; Prigent, Y.; Bodo, B. J.
Am. Chem. Soc. 1992, 114, 2170.
14. Khodaei, M. M.; Khosropour, A. R.; Ghozati, K.
Tetrahedron Lett. 2004, 45, 3525, and references cited
therein.
15. Yamada, J.-I.; Yumoto, M.; Yamamoto, Y. Tetrahedron
Lett. 1989, 30, 4255.
16. Chini, M.; Crotti, P.; Macchia, F. Tetrahedron Lett. 1990,
31, 4661.
17. Cepanec, I.; Litvic, M.; Mikuldas, H.; Bartolincic, A.;
Vinkovic, V. Tetrahedron 2003, 59, 2435.
18. Rafiee, E.; Tangestaninejad, S.; Habibi, M. H.; Mirkhani,
V. Synth. Commun. 2004, 34, 3673.
19. Feth, G.; Richter, C. USP 1980, 4215220.
1-Chloro-3-(40-chlorophenylamino)-propan-2-ol
(2c)
was identified as the most active anti-fungal compound,
which exhibits more than 90% inhibition of A. fumigatus
in DDA assay at a concentration of 5.85 lg/ml per disc.
Compounds 2g and 2i were found to be the most active
against C. albicans; the MIC being 31.25 lg/ml. Com-
pounds 2e and 2i exhibited strong activity against S. ty-
phi whereas compound 2h was found to be the most
active against P. aeruginosa. Compound 2c emerged as
a potential lead for the development of anti-fungal drug
candidate even though its activity was less than that of
amphotericin B, but it was many fold less toxic than
the standard anti-fungal agent. Further, compounds 2e
and 2i having about half the activity of the standard
anti-bacterial compound tetracycline and less toxicity
than this standard compound may be potential candi-
dates for the development as anti-bacterial drug candi-
date/hit compound.
´
20. Laguerre, M.; Boyer, C.; Carpy, A.; Leger, J. M.; Panconi,
E.; Vaugien, B.; Cognic, F. Eur. J. Med. Chem. 1993, 28,
77.
21. 1-Chloro-3-(30-chlorophenylamino)-propan-2-ol (2b). It
was obtained as brown oil (1.60 g) in 73% yield.
Rf = 0.25 in 15% ethyl acetate in petroleum ether. IR
(nujol): 3401 (NH, OH), 2923, 1599, 1504, 1251, 1091, 988
Acknowledgments
1
and 766 cmꢀ1; H NMR (300 MHz, CDCl3): d 3.17 (1H,
We are thankful to the Council of Scientific and Indus-
trial Research (CSIR, New Delhi) and Department of
Scientific and Industrial Research (DSIR, New Delhi)
for the financial assistance.
dd, J = 13.2 and 7.2 Hz, C-3Ha), 3.42 (1H, dd, J = 13.2
and 4.3 Hz, C-3Hb), 3.63 (2H, m, C-1H), 4.04 (1H, m,
C-2H), 6.48 (1H, d, J = 8.0 Hz, C-60H), 6.61 (1H, br s,
C-20H), 6.69 (1H, d, J = 7.7 Hz, C-40H) and 7.07 (1H, t,
J = 8.1 Hz, C-50H); 13C NMR (75.5 MHz, CDCl3): d 45.82
and 46.61 (C-1 and C-3)), 68.79 (C-2), 110.60, 115.12 and
117.02 (C-20, C-40 and C-60), 129.33 (C-50), 134.12 (C-30)
and 144.05 (C-10); HRMS (ESI positive mode): calculated
for C9H11NOCl2 [M]+ 219.0218, observed [M]+ 219.0220.
22. 1-Chloro-3-(20,30-dichlorophenylamino)-propan-2-ol (2d).
It was obtained as colourless oil (2.00 g) in 79% yield.
Rf = 0.38 in 15% ethyl acetate in petroleum ether. IR
(nujol): 3415 (NH, OH), 2858, 1589, 1503, 1322, 1279,
Supplementary data
Supplementary data associated with this article can be
1
1040 and 762 cmꢀ1; H NMR (300 MHz, CDCl3): d 2.47
(1H, brs, OH), 3.32 (1H, dd, J = 12.4 and 6.1 Hz, C-3Ha),
3.43 (1H, dd, J = 13.0 and 4.5 Hz, C-3Hb), 3.67 (2H, m, C-
1H), 4.10 (1H, m, C-2H), 4.79 (1H, br s, NH), 6.60 (1H, d,
J = 8.1 Hz, C-60H), 6.82 (1H, d, J = 7.9 Hz, C-40H) and
7.06 (1H, t, J = 8.0 Hz, C-50H); 13C NMR (75.5 MHz,
CDCl3): d 46.95 and 47.63 (C-1 and C-3)), 69.88 (C-2),
109.43 (C-50), 118.85 (C-40 and C-60), 127.91 (C-30), 135.00
(C-20) and 145.34 (C-10); HRMS (ESI positive mode):
calculated for C9H10NOCl3 [M]+ 252.9828, observed [M]+
252.9815.
References and notes
1. Musiol, R.; Jampilek, J.; Buchta, V.; Silva, L.; Niedbala, H.;
Podeszwa, B.; Palka, A.; Majerz-Maniecka, K.; Oleksyn,
B.; Polanski, J. Bioorg. Med. Chem. 2006, 14, 3592.
2. De Luca, L. Curr. Med. Chem. 2006, 13, 1.
3. Jampilek, J.; Dolezal, M.; Kunes, J.; Buchta, V.; Silva, L.;
Kralova, K. J. Med. Chem. 2005, 1, 591.
4. Kiran, I.; Ilhan, S.; Akar, T.; Tur, L.; Erol, E. J. Biosci.
2005, 60, 686.
5. Chhillar, A. K.; Arya, P.; Mukherjee, C.; Kumar, P.;
Yadav, Y.; Sharma, A. K.; Yadav, V.; Gupta, J.;
Dabur, R.; Jha, H. N.; Watterson, A. C.; Parmar, V.
23. 1-Chloro-3-(20,50-dichlorophenylamino)-propan-2-ol (2f).
It was obtained as reddish oil (1.75 g) in 69% yield.
Rf = 0.44 in 15% ethyl acetate in petroleum ether. IR